US Patent 7994171 Compounds for the treatment of hepatitis C
Patent 7994171 was granted and assigned to Bristol-Myers Squibb on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+260 characters)
Article
Patent abstract
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Andrew Nickel0
Brett R. Beno0
John A. Bender0
John F. Kadow0
Kap-Sun Yeung0
Katharine A. Grant-Young0
Kyle E. Parcella0
Piyasena Hewawasam0
Ying Han0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07994171 Compounds for the treatment of hepatitis C US Patent 7994171 Compounds for the treatment of hepatitis C
Infobox
Patent Number
079941710
Patent Number
79941710
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079941710
Date of Patent
August 9, 2011
0Patent Application Number
127214230
Date Filed
March 10, 2010
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07994171 Compounds for the treatment of hepatitis C
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07994171
Date of patent
August 9, 2011
Patent application number
12721423
Date Filed
March 10, 2010
Patent primary examiner
Find more entities like US Patent 7994171 Compounds for the treatment of hepatitis C
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
